NEOG
Neogen Corporation
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Buy
+50/100
Last price
13.22
▲ 0.21 (1.63%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
13.35
Prev close
13.01
Day high
13.22
Day low
11.86
Volume
5.95M
Market cap
$2.61B
P/E (TTM)
—
52W range
5.37 – 14.26
Day trading desk
Gap from prior close
+2.61%
Prior close 13.01
VWAP
12.43
+6.35% from price
Relative volume
3.41×
Unusually busy
Session range
13.89%
11.81 – 13.45
Position in range
86%
Near session high
ATR (14D)
0.68
5.16% of price
Prior day high
13.06
PDH
Prior day low
11.98
PDL
Bid / ask spread
—
Quote not published
Session volume
9.69M
Avg 2.84M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-6.05%
-8.0%
1M
+1.10%
-0.1%
3M
+29.16%
+24.6%
6M
+19.84%
+1.7%
YTD
+71.10%
+56.9%
1Y
+97.36%
+80.9%
3Y
-35.49%
-117.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
16 more panels on NEOG open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
1.64M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 14, 26 | STACEY JENNIFER EVANS Officer |
STOCK | 38.63K | $450.00K | Direct |
| Aug 14, 26 | RIGGSBEE RICHARD BRYAN Chief Financial Officer |
STOCK | 51.50K | $600.00K | Direct |
| Aug 14, 26 | RANALLI TAMARA A Officer |
STOCK | 25.75K | $300.00K | Direct |
| Aug 14, 26 | NASSIF MIKHEAL Chief Executive Officer |
STOCK | 141.63K | $1.65M | Direct |
| Aug 4, 26 | NASSIF MIKHEAL Chief Executive Officer |
BUY | 370 | $4.37K | Indirect |
| May 18, 26 | ROCKLIN AMY M Former |
CONVERSION | 35.18K | $326.85K | Direct |
| May 4, 26 | MOYLAN JOHN PATRICK Officer |
CONVERSION | 4.56K | $43.44K | Direct |
| May 1, 26 | STACEY JENNIFER EVANS Officer |
STOCK | 39.35K | $375.00K | Direct |
| Feb 17, 26 | NASSIF MIKHEAL Chief Executive Officer |
BUY | 23 | $252 | Indirect |
| Feb 2, 26 | NASSIF MIKHEAL Chief Executive Officer |
BUY | 49 | $486 | Indirect |
| Jan 16, 26 | NASSIF MIKHEAL Chief Executive Officer |
BUY | 137 | $1.28K | Indirect |
| Jan 7, 26 | RANALLI TAMARA A Officer |
STOCK | 50.81K | $375.00K | Direct |
| Jan 7, 26 | RANALLI TAMARA A Officer |
STOCK | 101.63K | $750.00K | Direct |
| Dec 1, 25 | NAEMURA DAVID HARTMAN Former |
CONVERSION | 12.91K | $77.21K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ADENT JOHN EDWARD |
Former | 363.08K | Conversion of Exercise of derivative security |
BOEHM WILLIAM T |
Director | 47.91K | Conversion of Exercise of derivative security |
BOREL JAMES C. |
Director | 94.57K | Conversion of Exercise of derivative security |
JONES DOUGLAS EDWARD |
Former | 100.88K | Conversion of Exercise of derivative security |
NAEMURA DAVID HARTMAN |
Former | 90.39K | Conversion of Exercise of derivative security |
NASSIF MIKHEAL |
Chief Executive Officer | 141.63K | Stock Award(Grant) |
RIGGSBEE RICHARD BRYAN |
Chief Financial Officer | 51.50K | Stock Award(Grant) |
ROCKLIN AMY M |
Former | 82.18K | Conversion of Exercise of derivative security |
STACEY JENNIFER EVANS |
Officer | 38.63K | Stock Award(Grant) |
TOBIN JAMES P |
Director | 43.35K | Conversion of Exercise of derivative security |
Fundamentals
Market cap$2.61B
Enterprise value$3.24B
Revenue (TTM)$870.40M
Gross profit$408.50M
EBITDA$94.70M
Net income$-7.90M
EPS (TTM)$-0.04
Free cash flow$69.50M
Total cash$185.50M
Total debt$812.60M
Book value / share$9.61
Shares outstanding218.11M
Float217.08M
Short % of float6.84%
Dividend yield0.00%
Beta (5Y)1.79
Valuation & profitability ratios
Trailing P/E—
Forward P/E31.47
PEG ratio0.66
Price / sales—
Price / book1.24
EV / revenue3.72
EV / EBITDA34.16
Gross margin46.93%
Operating margin1.38%
Profit margin-0.91%
Return on equity-0.38%
Return on assets-0.40%
Debt / equity38.83
Current ratio3.82
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $870.40M | $894.70M | $924.20M | $822.45M | -2.7% |
| Operating revenue | $870.40M | $894.70M | $924.20M | $822.45M | -2.7% |
| Cost of revenue | $461.90M | $473.30M | $460.30M | $416.49M | -2.4% |
| Gross profit | $408.50M | $421.40M | $463.90M | $405.95M | -3.1% |
| Research & development | $18.40M | $21.10M | $22.50M | $26.04M | -12.8% |
| Selling, general & admin | $411.70M | $402.00M | $382.80M | $342.40M | +2.4% |
| Total operating expense | $430.10M | $423.10M | $405.30M | $368.44M | +1.7% |
| Operating income | -$21.60M | -$1.70M | $58.60M | $37.52M | -1,170.6% |
| Net interest income | -$57.60M | -$68.50M | -$67.00M | -$52.80M | +15.9% |
| Pre-tax income | -$9.00M | -$1.13B | -$14.30M | -$22.04M | +99.2% |
| Tax provision | -$1.10M | -$41.10M | -$4.90M | $828.00K | +97.3% |
| Net income | -$7.90M | -$1.09B | -$9.40M | -$22.87M | +99.3% |
| Net income to common | -$7.90M | -$1.09B | -$9.40M | -$22.87M | +99.3% |
| Basic EPS | -0.04 | -5.03 | -0.04 | -0.11 | +99.2% |
| Diluted EPS | -0.04 | -5.03 | -0.04 | -0.12 | +99.2% |
| EBIT | $48.60M | -$1.06B | $52.70M | $33.92M | +104.6% |
| EBITDA | $170.50M | -$938.90M | $173.90M | $124.39M | +118.2% |
| Basic shares | 217.50M | 217.04M | 216.61M | 216.25M | +0.2% |
| Diluted shares | 217.50M | 217.04M | 216.61M | 216.25M | +0.2% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $185.50M | $129.00M | $170.61M | $163.24M | +43.8% |
| Cash & short-term investments | $185.50M | $129.00M | $170.94M | $245.57M | +43.8% |
| Accounts receivable | $146.80M | $153.40M | $173.00M | $153.25M | -4.3% |
| Inventory | $144.30M | $190.80M | $189.27M | $133.81M | -24.4% |
| Total current assets | $604.60M | $576.90M | $589.23M | $585.93M | +4.8% |
| Property, plant & equipment | $346.40M | $356.30M | $291.89M | $210.68M | -2.8% |
| Goodwill & intangibles | $2.37B | $2.47B | $3.65B | $3.74B | -4.4% |
| Total assets | $3.35B | $3.44B | $4.55B | $4.55B | -2.8% |
| Total current liabilities | $158.20M | $174.00M | $154.32M | $145.47M | -9.1% |
| Current debt | — | $19.30M | $2.45M | — | — |
| Long-term debt | $793.70M | $874.80M | $888.39M | $885.44M | -9.3% |
| Total debt | $793.70M | $894.10M | $890.84M | $885.44M | -11.2% |
| Total liabilities | $1.25B | $1.37B | $1.40B | $1.42B | -8.7% |
| Retained earnings | -$544.30M | -$536.40M | $555.62M | $565.04M | -1.5% |
| Shareholder equity | $2.09B | $2.07B | $3.14B | $3.13B | +1.0% |
| Working capital | $446.40M | $402.90M | $434.91M | $440.46M | +10.8% |
| Net tangible assets | -$272.30M | -$403.60M | -$503.14M | -$608.38M | +32.5% |
| Shares issued | 217.70M | 217.04M | 216.61M | 216.25M | +0.3% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | -$7.90M | -$1.09B | -$9.40M | -$22.87M | +99.3% |
| Depreciation & amortisation | $121.90M | $125.70M | $121.20M | $90.47M | -3.0% |
| Stock-based compensation | $13.40M | $17.30M | $13.80M | $10.18M | -22.5% |
| Change in working capital | $52.10M | -$6.00M | -$72.70M | -$24.20M | +968.3% |
| Operating cash flow | $83.20M | $58.20M | $35.30M | $41.03M | +43.0% |
| Capital expenditure | -$51.30M | -$104.60M | -$111.40M | -$65.76M | +51.0% |
| Investing cash flow | $70.50M | -$99.20M | -$29.30M | $201.04M | +171.1% |
| Financing cash flow | -$99.40M | -$1.60M | $1.90M | -$118.08M | -6,112.5% |
| Free cash flow | $31.90M | -$46.40M | -$76.10M | -$24.73M | +168.8% |
| End cash position | $185.50M | $129.00M | $170.60M | $163.24M | +43.8% |
| Line item | 2026-05-31 | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $225.30M | $211.20M | $224.69M | $209.19M | $225.46M | +6.7% |
| Operating revenue | $225.30M | $211.20M | $224.69M | $209.19M | $225.46M | +6.7% |
| Cost of revenue | $117.50M | $112.20M | $118.01M | $114.22M | $132.60M | +4.7% |
| Gross profit | $107.80M | $99.00M | $106.68M | $94.97M | $92.86M | +8.9% |
| Research & development | $4.90M | $3.80M | $4.56M | $5.13M | $6.31M | +28.9% |
| Selling, general & admin | $99.80M | $98.50M | $107.50M | $105.94M | $99.80M | +1.3% |
| Total operating expense | $104.70M | $102.30M | $112.06M | $111.06M | $106.11M | +2.3% |
| Operating income | $3.10M | -$3.30M | -$5.38M | -$16.09M | -$13.25M | +193.9% |
| Net interest income | -$13.90M | -$13.90M | -$14.26M | -$15.52M | -$16.48M | 0.0% |
| Pre-tax income | -$12.10M | -$20.30M | -$20.36M | $43.81M | -$631.20M | +40.4% |
| Tax provision | -$800.00K | -$3.30M | -$4.44M | $7.47M | -$19.01M | +75.8% |
| Net income | -$11.30M | -$17.00M | -$15.92M | $36.34M | -$612.20M | +33.5% |
| Net income to common | -$11.30M | -$17.00M | -$15.92M | $36.34M | -$612.20M | +33.5% |
| Basic EPS | -0.05 | -0.08 | -0.07 | 0.17 | -2.82 | +37.5% |
| Diluted EPS | -0.05 | -0.08 | -0.07 | 0.17 | -2.82 | +37.5% |
| EBIT | $1.80M | -$6.40M | -$5.52M | $60.25M | -$614.07M | +128.1% |
| EBITDA | $36.80M | $22.52M | $23.41M | $89.31M | -$577.62M | +63.4% |
| Basic shares | 217.70M | 217.70M | 217.53M | 217.30M | 217.04M | 0.0% |
| Diluted shares | 217.70M | 217.70M | 217.53M | 217.33M | 217.04M | 0.0% |
| Line item | 2026-05-31 | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $185.50M | $159.90M | $145.34M | $138.88M | $129.00M | +16.0% |
| Cash & short-term investments | $185.50M | $159.90M | $145.34M | $138.88M | $129.00M | +16.0% |
| Accounts receivable | $146.80M | $137.10M | $132.00M | $138.46M | $153.40M | +7.1% |
| Inventory | $144.30M | $161.70M | $162.77M | $193.41M | $190.80M | -10.8% |
| Total current assets | $604.60M | $590.00M | $574.58M | $524.06M | $576.90M | +2.5% |
| Property, plant & equipment | $346.40M | $347.60M | $347.46M | $362.89M | $356.30M | -0.3% |
| Goodwill & intangibles | $2.37B | $2.39B | $2.41B | $2.46B | $2.47B | -1.0% |
| Total assets | $3.35B | $3.36B | $3.36B | $3.38B | $3.44B | -0.4% |
| Total current liabilities | $158.20M | $150.60M | $147.05M | $146.21M | $174.00M | +5.0% |
| Current debt | — | — | — | — | $19.30M | — |
| Long-term debt | $793.70M | $793.30M | $792.93M | $792.53M | $874.80M | +0.1% |
| Total debt | $793.70M | $793.30M | $792.93M | $792.53M | $894.10M | +0.1% |
| Total liabilities | $1.25B | $1.26B | $1.26B | $1.26B | $1.37B | -0.3% |
| Retained earnings | -$544.30M | -$533.00M | -$516.01M | -$500.09M | -$536.40M | -2.1% |
| Shareholder equity | $2.09B | $2.10B | $2.10B | $2.12B | $2.07B | -0.5% |
| Working capital | $446.40M | $439.40M | $427.53M | $377.86M | $402.90M | +1.6% |
| Net tangible assets | -$272.30M | -$287.20M | -$300.93M | -$336.38M | -$403.60M | +5.2% |
| Shares issued | 217.70M | 217.67M | 217.53M | 217.30M | 217.04M | +0.0% |
| Line item | 2026-05-31 | 2026-02-28 | 2025-11-30 | 2025-08-31 | 2025-05-31 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$11.30M | -$17.01M | -$15.92M | $36.34M | -$612.20M | +33.6% |
| Depreciation & amortisation | $35.00M | $28.92M | $28.93M | $29.05M | $36.45M | +21.0% |
| Stock-based compensation | $3.00M | $1.10M | $4.34M | $4.96M | $4.33M | +172.7% |
| Change in working capital | $10.80M | $13.03M | $6.80M | $21.47M | $14.81M | -17.1% |
| Operating cash flow | $30.20M | $22.70M | $19.44M | $10.85M | $16.54M | +33.0% |
| Capital expenditure | -$4.00M | -$11.63M | -$11.67M | -$24.00M | -$16.14M | +65.6% |
| Investing cash flow | -$4.00M | -$11.56M | -$11.67M | $97.72M | -$15.93M | +65.4% |
| Financing cash flow | -$300.00K | $744.00K | -$451.00K | -$99.39M | -$2.11M | -140.3% |
| Free cash flow | $26.20M | $11.07M | $7.78M | -$13.15M | $406.00K | +136.6% |
| End cash position | $185.50M | $159.90M | $145.34M | $138.88M | $129.00M | +16.0% |
Options analytics
Put / call volume
0.98
Call-heavy session
Put / call open interest
0.66
Positioning, not flow
Max pain
12.50
+4.5% from spot
ATM implied vol
101.2%
Nearest strike to spot
Skew (10% OTM)
+3.9%
Puts bid over calls
Call volume
1.52K
Contracts, this expiry
Put volume
1.48K
Contracts, this expiry
Heaviest call OI
12.50
8.31K contracts
Heaviest put OI
7.50
5.18K contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| May 2026 | 0.06 | 0.09 | +58.8% |
| Feb 2026 | 0.05 | 0.09 | +68.8% |
| Nov 2025 | 0.07 | 0.10 | +50.0% |
| Aug 2025 | 0.04 | 0.04 | +9.1% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.05 | 3 | $208.18M | -0.5% |
| Next quarter | 0.09 | 3 | $228.63M | +1.8% |
| Current year | 0.31 | 3 | $883.17M | +1.5% |
| Next year | 0.38 | 3 | $865.65M | -2.0% |
Analyst targets & ownership
Mean target$14.00
High target$14.00
Low target$14.00
Implied upside5.88%
Analyst count3
ConsensusBUY
Strong buy / Buy2 / 1
Hold1
Sell / Strong sell0 / 0
Held by insiders0.75%
Held by institutions110.95%
Institutions holding406
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
12.96
+2.02% from price
SMA 20
12.76
-6.28% from price
SMA 50
12.02
-0.54% from price
SMA 100
10.64
+24.33% from price
SMA 200
10.05
+19.05% from price
EMA 12
12.71
+4.06% from price
EMA 26
12.52
+5.64% from price
EMA 50
11.97
+10.45% from price
RSI (14)
44.2
Neutral
MACD (12,26,9)
0.19
Hist -0.18
ATR (14)
0.68
5.71% of price
Realised vol 30D
47.1%
Annualised
Bollinger upper
14.22
20, 2σ
Bollinger lower
11.30
20, 2σ
50 / 200 cross
Golden
12.02 vs 10.05
Trend bias
Above 200
+19.05%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.51
More volatile than market
Correlation to SPY
0.32
Loosely linked
Realised vol 30D
47.1%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-27.7%
Peak to trough
Max drawdown 5Y
-90.6%
Peak to trough
ATR 14
0.68
5.71% of price
Beta (reported)
1.79
5Y monthly, from filing
Short interest
Shares short
11.17M
Prior 9.93M
Change vs prior
+12.4%
Shorts adding
% of float
6.84%
Normal
% of shares out
5.12%
Against total outstanding
Days to cover
5.7
Crowded exit
Float
217.08M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 30, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Aug 26, 26 | Piper Sandler | UPGRADE | Neutral | Overweight |
| Aug 3, 26 | Piper Sandler | MAINTAINED | Neutral | Neutral |
| Jan 12, 26 | Piper Sandler | MAINTAINED | Neutral | Neutral |
| Jan 9, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Dec 10, 25 | CJS Securities | UPGRADE | Market Perform | Market Outperform |
| Oct 16, 25 | Piper Sandler | MAINTAINED | Neutral | Neutral |
| Sep 29, 25 | CJS Securities | INITIATED | — | Market Perform |
| Jul 29, 25 | William Blair | DOWNGRADE | Outperform | Market Perform |
| Jun 30, 25 | Guggenheim | MAINTAINED | Buy | Buy |
| Apr 22, 25 | Piper Sandler | MAINTAINED | Neutral | Neutral |
| Apr 14, 25 | Piper Sandler | MAINTAINED | Neutral | Neutral |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split2:1
Split dateJun 7, 2021
SEC filings
Proxy Statements
DEFA14A · 2026-09-28
Annual Report to Shareholders
ARS · 2026-08-21
Corporate Changes & Voting Matters
8-K · 2026-08-07
Corporate Changes & Voting Matters
8-K · 2026-07-30
Annual report of employee stock purchase
11-K · 2026-06-25
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-05-20
Corporate Changes & Voting Matters
8-K · 2026-04-20
Corporate Changes & Voting Matters
8-K · 2026-04-09
Headlines
What Neogen (NEOG) Said on Its Q1 Earnings Call
MarketBeat · 5h ago
Compared to Estimates, Neogen (NEOG) Q1 Earnings: A Look at Key Metrics
Zacks · 6h ago
Neogen’s (NASDAQ:NEOG) Q3 CY2026: Strong Sales, Stock Soars
StockStory · 7h ago
Neogen stock up 8% on better-than-expected Q1 results, guidance
Investing.com · 7h ago
Neogen Fiscal Q1 Adjusted Earnings, Revenue Rise; Fiscal 2027 Revenue Guidance Raised
MT Newswires · 8h ago
Neogen (NEOG) Q1 Earnings and Revenues Beat Estimates
Zacks · 8h ago
Neogen: Fiscal Q1 Earnings Snapshot
Associated Press · 8h ago
Neogen Reports First-Quarter Financial Results for Fiscal Year 2027
Business Wire · 8h ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.